SARS-CoV-2 outbreak in Iran: The dynamics of the epidemic and evidence on two independent introductions.
COVID-19
Iran
SARS-CoV-2
phylogenetic study
whole genome sequencing
Journal
Transboundary and emerging diseases
ISSN: 1865-1682
Titre abrégé: Transbound Emerg Dis
Pays: Germany
ID NLM: 101319538
Informations de publication
Date de publication:
May 2022
May 2022
Historique:
revised:
05
04
2021
received:
10
12
2020
accepted:
06
04
2021
pubmed:
10
4
2021
medline:
7
5
2022
entrez:
9
4
2021
Statut:
ppublish
Résumé
The SARS-CoV-2 virus has been rapidly spreading globally since December 2019, triggering a pandemic, soon after its emergence. While Iran was among the first countries confronted with rapid spread of virus in February 2020, no real-time SARS-CoV-2 whole-genome tracking in early phase of outbreak was performed in the country. To address this issue, we provided 50 whole-genome sequences of viral isolates ascertained from different geographical locations in Iran during March-July 2020. The corresponding analysis on origins, transmission dynamics and genetic diversity of SARS-CoV-2 virus, represented at least two introductions of the virus into the country, constructing two major clusters defined as B.4 and B.1*. The first entry of the virus might have occurred around very late 2019/early 2020, as suggested by the time to the most recent common ancestor, followed by a rapid community transmission that led to dominancy of B.4 lineage in early epidemic till the end of June. Gradually, reduction in dominancy of B.4 occurred possibly as a result of other entries of the virus, followed by surge of B.1* lineages, as of mid-May. Remarkably, variation tracking of the virus indicated the increase in frequency of D614G mutation, along with B.1* lineages, which showed continuity till October 2020. The increase in frequency of D614G mutation and B.1* lineages from mid-May onwards predicts a rapid viral transmission that may push the country into a critical health situation followed by a considerable change in composition of viral lineages circulating in the country.
Identifiants
pubmed: 33835709
doi: 10.1111/tbed.14104
pmc: PMC8251331
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1375-1386Subventions
Organisme : Iran Vice deputy for Research and Technology at Iran Ministry of Health and Medical Education
ID : 99/801/A/6/7586
Informations de copyright
© 2021 Wiley-VCH GmbH.
Références
Virus Evol. 2020 Apr 10;6(1):veaa027
pubmed: 32296544
Nature. 2021 Apr;592(7852):116-121
pubmed: 33106671
Appl Environ Microbiol. 2009 Dec;75(23):7537-41
pubmed: 19801464
Nat Med. 2020 Sep;26(9):1405-1410
pubmed: 32678356
Cell. 2020 Aug 20;182(4):812-827.e19
pubmed: 32697968
Nat Commun. 2020 Sep 11;11(1):4541
pubmed: 32917884
Bioinformatics. 2018 Sep 1;34(17):i884-i890
pubmed: 30423086
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
Nat Commun. 2020 Nov 25;11(1):5986
pubmed: 33239633
Mol Biol Evol. 2020 May 1;37(5):1530-1534
pubmed: 32011700
J Neuroimmune Pharmacol. 2020 Dec;15(4):574-577
pubmed: 32930936
Iran J Kidney Dis. 2020 Sep;14(5):331-334
pubmed: 32943587
Cell. 2020 Aug 20;182(4):794-795
pubmed: 32697970
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
J Virol. 2018 Jun 29;92(14):
pubmed: 29720522
Nat Microbiol. 2020 Nov;5(11):1403-1407
pubmed: 32669681
Front Microbiol. 2020 Jul 22;11:1800
pubmed: 32793182
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
Bull World Health Organ. 2020 Jul 01;98(7):495-504
pubmed: 32742035
Transbound Emerg Dis. 2022 May;69(3):1375-1386
pubmed: 33835709
Mol Biol Evol. 2013 Apr;30(4):772-80
pubmed: 23329690
Proc Natl Acad Sci U S A. 2020 Sep 22;117(38):23652-23662
pubmed: 32868447
BMC Evol Biol. 2007 Nov 08;7:214
pubmed: 17996036
Bioinformatics. 2018 Dec 1;34(23):4121-4123
pubmed: 29790939
Euro Surveill. 2017 Mar 30;22(13):
pubmed: 28382917
Virus Evol. 2016 Apr 09;2(1):vew007
pubmed: 27774300
Infect Genet Evol. 2020 Nov;85:104557
pubmed: 32950697